Cite
HARVARD Citation
Bruni, C. et al. (2020). The switch from etanercept originator to SB4: data from a real-life experience on tolerability and persistence on treatment in joint inflammatory diseases. Therapeutic advances in musculoskeletal disease. p. . [Online].